Duodenal Cancer, commonly referred to as small bowel cancer or small intestine cancer, is typically an adenocarcinoma (occasionally a sarcoma, lymphoma, or a carcinoid tumors) that begins in the duodenum, the first part of the small intestine. Individuals with familial adenomatous polyposis (FAP) have a very high risk of duodenal cancer, thus preemptive removal of the duodenum. Other risk factors include Crohn's Disease, coeliac disease, and Peutz-Jegher's syndrome. Treatments include surgery, chemotherapy, radiation therapy, and biological therapy.
Duodenal Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Duodenal Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1279 products for the study of Duodenal Cancer that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.